Aspen Pharmacare Holdings Limited (APN.JO)

23,206.00 -329.00 (-1.40%) 收市：05:00PM SAST

Aspen Pharmacare Holdings Limited

Aspen Place
9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge
Durban
South Africa
27 31 580 8600
https://www.aspenpharma.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 8,612

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Stephen Bradley Saad BCom, CA(SA)	Group CEO & Executive Director	19.04M	無	1964
Mr. Sean M. Capazorio	Group CFO & Executive Director	10.36M	無	1967
Ms. Lorraine Hill	Group Chief Operations Officer & Responsible Pharmacist	11.17M	無	1964
Mr. Michael Guy Attridge B.Com., CA(SA)	Group Chief Advisor	8.4M	無	1961
Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA	Group Chief Corporate Services Officer & Executive Director	7.82M	無	1975
Ms. Zizipho Mmango	Group Chief Strategic Development Officer	7.82M	無	1985
Sibongakonke Nkosi	Investor Relations Manager	無	無	無
Mr. Trevor Julian Ziman	Regional Chief Executive Officer of Asia Pacific	無	無	1972
Mr. Samer Kassem	Chief Executive Officer of Aspen Global Incorporated	無	無	1975
Ms. Raeesa Khan	Group Company Secretary	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 ZAc。

描述

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

公司管治

截至 2024年5月1日 止，Aspen Pharmacare Holdings Limited 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中：7；董事會：4；股東權利：2；現金賠償：6。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。